Bill

Bill > HR3520


US HR3520

US HR3520
Stem Cell Therapeutic and Research Reauthorization Act of 2019


summary

Introduced
06/26/2019
In Committee
06/27/2019
Crossed Over
Passed
Dead
12/31/2020

Introduced Session

116th Congress

Bill Summary

Modifies and reauthorizes through FY2024 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant. It also reauthorizes through FY2024 the Stem Cell Therapeutic and Research Act of 2005, which provides for the collection and maintenance of new units of high-quality cord blood. The bill requires the Advisory Council on Blood Stem Cell Transplantation to convene at least twice per calendar year.

AI Summary

This bill modifies and reauthorizes through fiscal year 2024 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow or umbilical cord blood transplant. It also reauthorizes through fiscal year 2024 the Stem Cell Therapeutic and Research Act of 2005, which provides for the collection and maintenance of new units of high-quality cord blood. Additionally, the bill requires the Advisory Council on Blood Stem Cell Transplantation to convene at least twice per calendar year.

Committee Categories

Business and Industry, Health and Social Services

Sponsors (4)

Last Action

Referred to the Subcommittee on Health. (on 06/27/2019)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...